DOYU News and Press, DouYu International Holdings Limited From 05/11/23

2023-05-11 05:21:10 ET Summary Regulators plan to review DOYU's platform for a month after detecting inappropriate content. DouYu's shares might experience valuation multiple contraction with investors' attention drawn to the company's regulatory risks. If DOYU's price-to-sale...

DouYu International Holdings Limited Responds to Regulatory Review PR Newswire WUHAN, China , May 9, 2023 /PRNewswire/ -- DouYu International Holdings Limited ("DouYu" or the "Company") (Nasdaq: DOYU), a leading game-centric live streaming platform in China a...

2023-05-08 08:17:24 ET MDJM ( MDJH ) -27% . Catalent ( CTLT ) -20% on rejecting TRC Capital's tender offer for shares BioXcel Therapeutics ( BTAI ) -15% after Q1 earning release . Baosheng Media Group Holdings ( BAOS ) -13% . Minim (...

DouYu International Holdings Limited to Report First Quarter 2023 Financial Results on May 18, 2023 PR Newswire WUHAN, China , May 4, 2023 /PRNewswire/ -- DouYu International Holdings Limited ("DouYu" or the "Company") (Nasdaq: DOYU), a leading game-centric ...

2023-03-20 12:52:05 ET DouYu International Holdings Limited (DOYU) Q4 2022 Earnings Conference Call March 20, 2023 7:00 AM ET Company Participants Lingling Kong - Investor Relations Director Hao Cao - Vice President, Finance Shaojie Chen - Chairman and Chief Exec...

2023-03-20 04:37:57 ET DouYu International press release ( NASDAQ: DOYU ): Q4 Non-GAAP EPADS of $0.00 beats by $0.01 . Revenue of $243.73M (-33.3% Y/Y) beats by $1.63M . Average mobile MAUs in the fourth quarter of 2022 decreased b...

DouYu International Holdings Limited Reports Fourth Quarter and Full Year 2022 Unaudited Financial Results PR Newswire WUHAN, China , March 20, 2023 /PRNewswire/ -- DouYu International Holdings Limited ("DouYu" or the "Company") (Nasdaq: DOYU), a leading game-cen...

2023-03-17 14:27:08 ET DouYu International ( NASDAQ: DOYU ) is scheduled to announce Q4 earnings results on Monday, March 20th, before market open. The consensus EPS Estimate is -$0.01 and the consensus Revenue Estimate is $242.1M. Over the last 2 years, DOYU has bea...

DouYu International Holdings Limited to Report Fourth Quarter and Full Year 2022 Financial Results on March 20, 2023 PR Newswire WUHAN, China , March 6, 2023 /PRNewswire/ -- DouYu International Holdings Limited ("DouYu" or the "Company") (Nasdaq: DOYU), a leading...

Reata Pharmaceuticals ( RETA ) +175% Pharmaceuticals up 192% on Friedreich's ataxia drug omaveloxolone approval. OncoSec Medical  ( ONCS ) +94% . Lionheart III  ( LION ) +53% . Sarepta Therapeutics ( SRPT ) +15% gains 18% as Morgan Stanley u...